Terminal Malignant Tumor Patients
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Pathologically confirmed diagnosis of malignant tumor; (2) Expected survival time of less than 12 months; (3)No standard anti-tumor treatment options available; (4) Complete clinical data, including age, sex, dietary intake, physical fitness, respiration, consciousness, systolic blood pressure, pulse, nutrition, organ condition, axillary temperature, urine output, edema, oxygen saturation, etc.; (5) Signed consent form for waiving invasive resuscitation measures such as cardiopulmonary resuscitation and endotracheal intubation; (6) Permitted treatments include: enteral and parenteral nutritional support, blood product transfusion, antibiotic infusion, and palliative treatments such as radiotherapy, chemotherapy, and surgery for symptom relief only (e.g., palliative radiotherapy for pain relief, intraperitoneal or intrapleural chemotherapy for effusions, colostomy, and central venous catheter placement).
Exclusion criteria
Exclusion criteria: (1) Systemic chemotherapy; (2) Radical radiotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival;C Statistic; | — |
Secondary
| Measure | Time frame |
|---|---|
| age;sex;dietary intake;physical fitness;respiration; consciousness;systolic blood pressure;pulse;nutrition;organ condition;axillary temperature;urine output;edema;oxygen saturation; | — |
Countries
China
Contacts
Department of Radiation Oncology, Taizhou Tumor Hospital